Project Grant R43GM150293
Award Date
9/6/23
Completion Date
9/5/24
Dollars Obligated
$296K
Federal Agency
National Institute of General Medical Sciences
Awardee
Indee. Inc. (SMXHTLFW8M47)
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This $300,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of a GMP-compliant E. coli dihydrofolate reductase (EDHFR) vector. This vector will be used to monitor the biodistribution and trafficking of investigational chimeric antigen receptor (CAR) T cell therapies through positron emission tomography (PET) imaging. The goals are to provide a...
This $500,000 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences, under the Biological Sciences federal grant program (CFDA 47.074), will support research to develop an end-to-end continuous manufacturing process for cell therapies using robotics and microfluidic technologies. The Georgia Tech Research Corporation will receive funding to create a more integrated workflow based on microfluidic device-enabled genetic engineering, cell expansion, and...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides funding to Yale University to develop a mechano-transduction platform that will enhance chimeric antigen receptor (CAR) T-cell therapies for cancer immunotherapy. The $195,766 award, effective from December 19, 2024 to November 30, 2026, aims to engineer force-sensitive coiled-coils that can measure forces along key immune receptors and integrate them into CARs to improve specificity...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), is funding the development of a new modular platform technology to mimic the structure and function of lymph nodes. The goal is to create an injectable hydrogel scaffold that can be used to program and expand T cells directly in living systems, which could improve...
This federal Project Grant award of $207,900 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286) supports research to develop a synthetic three-cell immunotherapy system. The goal is to engineer T cells, natural killer (NK) cells, and macrophages to express chimeric antigen receptors (CARs) and synthetic cytokine receptors (SCRs) in order to...
This $305,000 Small Business Innovation Research (SBIR) Phase I project, awarded by the National Science Foundation (NSF) under its Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop a microchip-based technology that uses sound waves and electric fields to manipulate cells and sequentially deliver customizable genetic materials. The goal is to make advanced cell engineering more accessible and enable a wider range of users to perform complex cellular modifications...
This National Science Foundation (NSF) Project Grant award, funded under the Engineering (CFDA 47.041) program, aims to develop a low-cost, mRNA-based manufacturing process for producing chimeric antigen receptor (CAR) T-cell therapies. The $250,000 award, effective May 1, 2025 through April 30, 2027, supports research to investigate protein expression and half-life in electroporated T-cells with mRNA, as well as the feasibility of using machine learning to create GMP-compliant...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA program 93.859 Biomedical Research and Research Training provides $350,000 to Fluidispec LLC to develop a new microfluidic/nanofluidic sample preparation platform. The goal is to improve single-cell and low-input proteomics analysis by enabling efficient extraction of proteins from cells, removal of contaminants, and improved protein denaturation. This platform is expected to enhance...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provides $275,000 to Dcan Biosciences LLC to develop an advanced microfluidic system for cancer diagnosis and monitoring. The system aims to isolate and assess circulating tumor cells (CTCs) and CTC clusters (CTCCs) from patient blood samples to enable highly sensitive and accurate liquid biopsies. Key objectives include designing a hybrid microfluidic device for...
Rattan Life Science Inc. received a $275,000 Project Grant award from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a platform for generating induced pluripotent stem cell-derived naïve CD4+ and CD8+ T cells with fidelity, reproducibility and scalability. The platform employs proprietary induced thymic epithelial cells to provide biologically relevant thymic positive selection signals during T cell differentiation,...